Schiavetti Amalia, Altavista Pierluigi, De Luca Laura, Andreoli Gianmarco, Megaro Giacomina, Versacci Paolo
Department of Pediatrics, "Sapienza" University, Rome, Italy.
Technical Unit for Radiation, Biology and Human Health, Casaccia ENEA Research Center, Rome, Italy.
Pediatr Blood Cancer. 2015 Sep;62(9):1637-44. doi: 10.1002/pbc.25558. Epub 2015 Apr 20.
The risk of renal impairment among survivors of childhood unilateral non-syndromic renal tumors (RTs) is not well defined. We evaluated the prevalence of and possible risk factors for renal impairment by estimating Glomerular Filtration Rate (eGFR) categories and chronic kidney disease (CKD) according to Kidney Disease: Improving Global Outcomes guidelines.
Since 1978, 82 patients were treated for RT, according to the International Society of Pediatric Oncology protocols in a single oncology unit. Of the 67 survivors, those who underwent nephron sparing surgery, those with short-term follow-up or those who had bilateral and/or syndromic disease or a second malignancy were excluded. Thirty-five adult survivors (14 M/21F; mean age 25 years; mean follow-up 20 years) were studied by chemistry, kidney ultrasound, blood pressure measurement, urinanalysis. Correlations were investigated between the prevalence of eGFR categories and CKD and gender, age at diagnosis, radiotherapy, chemotherapy, body mass index, time of follow-up, and age at study.
Eight (22.9%) survivors presented a mildly decreased eGFR (G2 category), the mean value was 80 ± 9.78 ml/min/1.73m(2) (median 84.5, range 63-89). Three (8.6%) survivors had CKD and a fourth (2.9%) hypertension. No significant correlations between G2 category and clinical variables were found.
A small percentage of survivors had CKD or hypertension after two decades. It is not yet clear whether a mildly decreased eGFR that does not constitute CKD in the absence of other markers (albuminuria and/or kidney ultrasound abnormalities) is likely to progress to CKD. Health promotion programs to avoid comorbidities are required.
儿童单侧非综合征性肾肿瘤(RTs)幸存者发生肾功能损害的风险尚不明确。我们根据改善全球肾脏病预后组织(KDIGO)的指南,通过估算肾小球滤过率(eGFR)类别和慢性肾脏病(CKD)来评估肾功能损害的患病率及可能的危险因素。
自1978年以来,82例患者按照国际小儿肿瘤学会的方案在单一肿瘤治疗中心接受了RT治疗。在67名幸存者中,排除了接受保留肾单位手术的患者、短期随访的患者、患有双侧和/或综合征性疾病或二次恶性肿瘤的患者。对35名成年幸存者(14名男性/21名女性;平均年龄25岁;平均随访20年)进行了血液化学检查、肾脏超声检查、血压测量和尿液分析。研究了eGFR类别和CKD的患病率与性别、诊断时年龄、放疗、化疗、体重指数、随访时间和研究时年龄之间的相关性。
8名(22.9%)幸存者的eGFR轻度降低(G2类别),平均值为80±9.78 ml/min/1.73m²(中位数84.5,范围63 - 89)。3名(8.6%)幸存者患有CKD,第四名(2.9%)患有高血压。未发现G2类别与临床变量之间存在显著相关性。
二十年后,一小部分幸存者患有CKD或高血压。在没有其他标志物(蛋白尿和/或肾脏超声异常)的情况下,尚不明确不构成CKD的轻度eGFR降低是否可能进展为CKD。需要开展健康促进项目以避免合并症。